IP Library Granted Patent US 10,315,042
Granted Patent B2
US 10,315,042 · App. 13/111,840 · Granted Jun 11, 2019

Device and method for providing a synergistic combination of phototherapy and a non-light energy modality to the brain

Inventors: Luis De Taboada (Carlsbad, CA); Jackson Streeter (Reno, NV)
Assignee: Pthera LLC
A61N5/0613A61N5/04A61F2007/0002A61N1/40A61N2/002A61N2/006A61N5/0618A61N5/0622A61N2005/007A61N2005/0602A61N2005/067A61N2005/0647A61N2005/0652A61N2005/0654A61N2005/0659A61N2005/0662A61N2007/0078A61N2007/0095
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,315,042
App. No.
13/111,840
Granted
Jun 11, 2019
Kind
B2
Abstract

Systems and methods that could reduce the potential for side effects while delivering a reduced amount of light energy and non-light energy to a patient while providing a desired therapeutic effect that might otherwise only be achievable with a higher dose of either the light energy or non-light energy administered alone are disclosed. In certain embodiments, disclosed is a system and method for treating a patient, by administering a combination of light therapy from a light energy source in addition to one, two, or more other non-light energy modalities to a target region of a patient for a synergistic therapeutic effect.

Claims (26)

1. A method for treating a patient's brain, comprising:

administering, to a target tissue of the patient's brain, an amount of light energy; and

administering, to the target tissue of the patient's brain, an amount of non-light energy, wherein the amount of non-light energy is a subtherapeutic amount of energy,

wherein the administrations of the amount of light energy and the amount of non-light energy occur within 24 hours of each other,

wherein the administrations of the amount of light energy and the amount of non-light energy produce a combined treatment effect to the patient that is greater than a sum of: (i) a treatment effect produced by administering the amount of light energy alone plus (ii) a treatment effect produced by administering the amount of non-light energy alone, and

wherein the time-averaged irradiance of the amount of light energy at the target tissue of the patient's brain is less than 100 mW/cm 2 .

2. The method of claim 1 , wherein the amount of light energy and the amount of non-light energy are administered concurrently.

3. The method of claim 1 , wherein the non-light energy is magnetic energy.

4. The method of claim 3 , wherein the administering the amount of non-light energy comprises trans-cranial magnetic stimulation.

5. The method of claim 1 , wherein the light energy has a wavelength between 630 nanometers to 1064 nanometers.

6. The method of claim 1 , wherein the light energy has a wavelength between 730 nanometers to 840 nanometers.

7. The method of claim 1 , wherein the light energy has a wavelength between 730 nanometers and 750 nanometers.

8. The method of claim 1 , wherein the amount of light energy and the amount of non-light energy are delivered in alternating pulses.

9. A method for treating a patient's brain, comprising:

administering, to a target tissue of the patient's brain, an amount of light energy; and

administering, to the target tissue of the patient's brain, an amount of non-light energy,

wherein the amount of non-light energy is a subtherapeutic amount of energy,

wherein the administration of the amount of light energy and the amount of non-light energy occur within 24 hours of each other, and

wherein the administrations of the amount of light energy and the amount of non-light energy produce a combined treatment effect to the patient that is greater than a sum of: (i) a treatment effect produced by administering the amount of light energy alone plus (ii) a treatment effect produced by administering the amount of non-light energy alone.

10. The method of claim 9 , wherein the combined treatment effect comprises improvement of neurologic function.

11. The method of claim 9 , wherein the amount of light energy and the amount of non-light energy are administered concurrently.

12. The method of claim 9 , wherein the non-light energy is magnetic energy.

13. The method of claim 9 , wherein the light energy has a wavelength between 630 nanometers to 1064 nanometers.

14. The method of claim 9 , wherein the light energy has a wavelength between 730 nanometers to 840 nanometers.

15. The method of claim 9 , wherein the light energy has a wavelength between 730 nanometers and 750 nanometers.

16. The method of claim 9 , wherein the amount of light energy and the amount of non-light energy are delivered in alternating pulses.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2016
From: DE TABOADA, LUIS H.
To: PTHERA, LLC
Reel/Frame 039797/0924 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2016
From: ADVANCED PHOTONICS SOLUTIONS, INC.
To: DE TABOADA, LUIS H.
Reel/Frame 039797/0961 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2012
From: PHOTOTHERA, INC.
To: PHOTOTHERA IP HOLDINGS, INC.
Reel/Frame 029082/0677 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2011
From: DE TABOADA, LUIS; STREETER, JACKSON
To: PHOTOTHERA, INC.
Reel/Frame 027009/0303 →
Continuity (11)
Continuation In Part 12617658 · Nov 12, 2009
Continuation 11482220 · Jul 7, 2006
Continuation 10682379 · Oct 9, 2003
Continuation In Part 10287432 · Nov 1, 2002
Provisional Application 61346420 · May 19, 2010
Provisional Application 60442693 · Jan 24, 2003
Provisional Application 60487979 · Jul 17, 2003
Provisional Application 60502147 · Sep 11, 2003
Provisional Application 60336436 · Nov 1, 2001
Provisional Application 60369260 · Apr 2, 2002
Related Publication 20120016174A1 · Jan 19, 2012
Cited By (4)
US 12,290,701 US 12,521,567 US 12,582,836 US 12,714,876